Documentation Standards Flashcards

A pharmacist discovers that a prescription dispensed yesterday contained a documentation error: the DIN was recorded correctly but the quantity dispensed field shows 90 tablets instead of the actual 30 tablets dispensed. The patient has already left with the correct quantity. Under Canadian pharmacy documentation standards, what is the MOST appropriate corrective action?

Answer: Make a late entry correction notation with the date, time, correct quantity, and pharmacist's initials, leaving the original erroneous entry visible

Documentation standards across Canadian jurisdictions require that errors in pharmacy records be corrected using a late entry or addendum approach — never by obliterating or deleting the original entry. The original erroneous entry must remain legible, and the correction must clearly indicate who made it, when, and what the accurate information is. This preserves the integrity of the audit trail, which is a fundamental principle of health record documentation.

A pharmacist in a hospital setting receives a verbal order for 'metoprolol 50 mg BID' from a physician during a code situation. The PEBC competency framework and most provincial standards require which of the following documentation steps to be completed FIRST after the emergency is resolved?

Answer: Transcribe the verbal order to the medication administration record and have the prescriber countersign within the timeframe specified by institutional policy

In emergency situations, verbal orders are permissible under most Canadian provincial standards and accreditation requirements (Accreditation Canada). The accepted practice is to document the verbal order immediately with the pharmacist's notation (including 'V.O.' from the physician's name), proceed with dispensing if clinically appropriate, and then ensure the prescriber countersigns within the institution's defined timeframe — typically 24 hours. Refusing to accept the order or requiring written documentation before the dose would be inappropriate in a genuine emergency.

Under NAPRA's Model Standards for Pharmacy Compounding of Non-Sterile Preparations, a Master Formulation Record (MFR) must be distinguished from a Compounding Record (CR). Which of the following statements CORRECTLY differentiates these two documents?

Answer: The MFR is the template containing the validated formula, equipment, and stability data; the CR is the batch-specific record documenting lot numbers, actual weights, and the compounder's verification for each preparation

NAPRA's compounding standards make a clear and critical distinction: the Master Formulation Record (MFR) is the 'recipe' — a permanent, validated document specifying formula, equipment, procedures, quality controls, and stability/BUD data. The Compounding Record (CR) is the individual batch record tied to a specific preparation, documenting actual ingredient sources and lot numbers, measured quantities, environmental conditions, and who performed and verified each step. They serve fundamentally different purposes and are both mandatory. The other options contain inaccuracies regarding interchangeability, retention periods, and oversight requirements.

A patient picks up a narcotic prescription and the pharmacist suspects the signature on the paper prescription may be forged. The pharmacist dispenses after contacting the prescriber's office and receiving verbal confirmation that the prescription is valid. Under the Controlled Drugs and Substances Act documentation requirements, which record must the pharmacist create and retain?

Answer: A notation in the dispensing record documenting the verbal confirmation, including the date, time, name of the individual contacted at the prescriber's office, and the pharmacist's initials

When a pharmacist has concerns about a prescription's authenticity and takes steps to verify it, the CDSA and professional standards require that this verification process be documented in the dispensing record. The notation serves as evidence that due diligence was exercised. A separate incident log is not mandated when no controlled substance incident (diversion, theft, or confirmed forgery) occurred. An amended prescription is unnecessary if the original was confirmed authentic. Reporting to the Office of Controlled Substances is required for actual incidents (e.g., theft, significant loss) not for routine verification of a prescription that turned out to be legitimate.

A pharmacist provides a Medscheck annual medication review and documents the encounter. Six months later, the patient requests a complete copy of their pharmacy records, including the Medscheck documentation, under provincial privacy legislation (aligned with PIPEDA). Which of the following BEST describes the pharmacist's obligation regarding the Medscheck record?

Answer: The pharmacist must provide the patient access to their Medscheck documentation as it is personal health information belonging to the patient, subject only to narrow exceptions such as if disclosure could harm a third party

Under PIPEDA and its provincial equivalents (e.g., Ontario's PHIPA, Alberta's HIA), individuals have a right to access their own personal health information, which includes clinical documentation created about them — such as Medscheck records. The fact that Medscheck is a government-funded program does not transfer ownership of the clinical record to the government; it remains the patient's health information held by the pharmacy. Exceptions to access rights are narrow (e.g., risk of harm to a third party, ongoing legal proceedings) and would not apply to a routine patient access request. Prescriber consent is not required for a patient to access their own records.

During a pharmacy audit, an inspector notes that the perpetual narcotic register shows a running balance of 142 tablets for a controlled substance, but a physical count reveals only 138 tablets. The discrepancy is 4 tablets over a 30-day period. Under the Narcotic Control Regulations, what is the THRESHOLD and TIMELINE that triggers a mandatory reporting obligation to the Office of Controlled Substances?

Answer: Any loss or theft that is 'significant' must be reported to the Office of Controlled Substances as soon as possible, and 'significant' is determined by the pharmacist's professional judgment considering the size of the practice, but there is no fixed numerical threshold in the regulations

The Narcotic Control Regulations (NCR) do not specify a fixed numerical threshold for reporting. Section 30 requires that any 'loss or theft' of a controlled substance be reported to Health Canada's Office of Controlled Substances 'as soon as possible.' The determination of whether a discrepancy constitutes a reportable loss versus a documentation error requires professional judgment — considering the pattern, magnitude relative to volume, whether explanations exist, and the practice context. This intentionally judgment-based standard means pharmacists cannot rely on a fixed number to avoid reporting; a pattern of small losses can be just as reportable as a single large one. The other options describe thresholds that do not exist in the regulations.